Cognitive Behavioral Therapy for COPD
CLIMB
Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression
1 other identifier
interventional
18
1 country
1
Brief Summary
The purpose of this study in patients with advanced COPD and depression is twofold:
- 1.Determine the feasibility and acceptability of a 6-session e-counseling intervention
- 2.Determine the efficacy of the e-counseling intervention on depressive symptoms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 24, 2012
CompletedFirst Posted
Study publicly available on registry
September 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 5, 2021
October 1, 2016
2.2 years
September 24, 2012
September 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Depressive Symptoms
Personal Health Questionnaire-9
8 weeks
Secondary Outcomes (5)
Dyspnea Intensity and Distress
8 weeks
Fatigue
8 weeks
Anxiety
8 weeks
Physical Activity
8 weeks
Quality of Life
8 weeks
Study Arms (2)
CLIMB (COPD Lifestyle, Mood, and Behavior)
EXPERIMENTALCounseling sessions for COPD and depression
Control
NO INTERVENTIONUsual Care
Interventions
Cognitive Behavioral Therapy delivered to patients via telephone aimed to improve mood and decrease depressive symptoms.
Eligibility Criteria
You may qualify if:
- COPD (FEV1/FVC \< 70% \& FEV1 \<80%; current or past smoking \>10pack-years)
- Depressed (PHQ-9 \>=10)
- Ability to speak, read and write English
- Willingness to use computer or study-issued tablet device
You may not qualify if:
- Current non-nicotine substance abuse or dependence
- Psychotic disorder
- Active suicide ideation with intent and plan
- Alzheimer's/dementia
- Currently receiving any psychotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Icahn School of Medicine at Mount Sinaicollaborator
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lynn F Reinke, PhD, RN
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 24, 2012
First Posted
September 27, 2012
Study Start
September 1, 2012
Primary Completion
December 1, 2014
Study Completion
October 1, 2016
Last Updated
October 5, 2021
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share